Improving sepsis risk assessment using a two-stage transformer model

FHS
March 17, 2025
10:51 am

Sepsis, a life-threatening condition caused by the body’s dysregulated response to infection, remains a leading cause of mortality in ICUs worldwide.

ESMO 2024: BMS cuts ties as Immatics regains full rights to bispecific

BMS is ending its $150m deal with Immatics to help develop its bispecific. Image credit: Getty Images / sesame. Immatics has been left with the

September 17, 2024

Bariatric surgery halted progression of liver disease in patients with obesity and cirrhosis, study finds

Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study offers one available option: bariatric surgery.

January 27, 2025

Mallinckrodt sells photopheresis platform Therakos for $925M

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.